You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CTY Conversion Disclosure
Nelsen Robert · SEC Form 4 · Filed Oct 19, 2026
Conversion
Calculated transaction value
$0
Nelsen Robert Director / Ten Percent Owner
CTY
Transaction date
Oct 19, 2026
Public filing date
Oct 19, 2026
Filing lag
Filed same day
CTY daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series B convertible preferred stock on Common Stock
- Quantity / price
- 1,845,585 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001104659-26-116965
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$3.06M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| City Therapeutics, Inc. CTY | Conversion | Oct 19, 2026 | $0 |
| City Therapeutics, Inc. CTY | Conversion | Oct 19, 2026 | Not reported |
| City Therapeutics, Inc. CTY Current | Conversion | Oct 19, 2026 | $0 |
| City Therapeutics, Inc. CTY | Conversion | Oct 19, 2026 | $0 |
| City Therapeutics, Inc. CTY | Conversion | Oct 19, 2026 | Not reported |
| City Therapeutics, Inc. CTY | Conversion | Oct 19, 2026 | Not reported |
| City Therapeutics, Inc. CTY | Buy | Oct 19, 2026 | $3.06M |
| City Therapeutics, Inc. CTY | Award | Oct 15, 2026 | $0 |